Tumour necrosis factor-alpha (-308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patients

International Journal of Immunogenetics

Volumn 43, Issue 6, 2016, Pages 376-382

  Tavares, M ^a   de Lima, C ^a   Fernandes, W ^a   Martinelli, V ^a   de Lucena, M ^b   Lima, F ^a   Telles, A ^a   Brandao L ^a   de Melo Junior M ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Barao de Lucena Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BRAZILIAN; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; ULCERATIVE COLITIS; ALLELE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84994381507     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/iji.12289     Document Type: Article

References (41)

1. Almeida, A.C., Ferreira, P., Canedo, F., Pereira, C., Figueiredo, R., Seruca, J.C. et al. (2004) Diferentes subtipos clinico patológicos da doença de Crohn podem ser definidos por variantes dos genes Nod2/Card15 e TNFa. Journal of Portuguesa Gastrenterology, 11, 302.
2. Andersen, V., Ernst, A., Christensen, J., Østergaard, M., Jacobsen, B.A., Tjønneland, A. et al. (2010) The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Medical Genetics, 11, 82.
3. Anderson, C.A., Boucher, G., Lees, C.W., Franke, A., D'Amato, M., Taylor, K.D. et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetic, 43, 246.
4. Bank, S., Andersen, P.S., Burisch, J., Pedersen, N., Roug, S., Galsgaard, J. et al. (2014) Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of Inflammatory Bowel Disease in a Danish cohort. PLoS One, 9, e98815.
5. Bouguen, G., Chevaux, J.B. & Peyrin-Biroulet, L. (2011) Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World Journal of Gastroenterology, 17, 547.
6. Fernandez, L., Martinez, A., Mendoza, J.L., Urcelay, E., Fernandez-Arquero, M., Garcia-Paredes, J. et al. (2005) Interleukin-10 polymorphisms in Spanish patients with IBD. Inflammatory Bowel Diseases, 11, 739.
7. Ferreira, A.C., Almeida, S., Tavares, M., Canedo, P., Pereira, F., Regalo, G. et al. (2005) NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflammatory Bowel Diseases, 11, 331.
8. Fowler, E.V., Eri, R., Hume, G., Johnstone, S., Pandeya, N., Lincoln, D. et al. (2005) TNF-alpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. Journal of Medical Genetics, 42, 523.
9. Garza-González, E., Pérez-Pérez, G.I., Mendonza-Ibarra, S.I., Flores-Gutiérrez, J.P. & Bosques-Padilla, F.J. (2010) Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population. International Journal of Immunogenetics, 37, 355.
10. Gasche, C., Scholmerich, J., Brynskov, J., D'Haens, G., Hanauer, S.B., Irvine, E.J. et al. (2000) A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflammatory Bowel Diseases, 6, 8.
11. Gibson, A.W., Edberg, J.C., Wu, J., Westendorp, R.G., Huizinga, T.W. & Kimberly, R.P. (2001) Novel single nucleotide polymorphism in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. Journal of Immunology, 166, 3915.
12. González, S., Rodrigo, L., Martínez-Borra, J., López-Vázquez, A., Fuertes, D., Niño, P., Cadahía, V., Saro, C., Dieguez, M.A. & López-Larrea, C. (2003) TNF- α -308A promoter polymorphism is assoaciated with enhanced TNF- α production and inflammatory activity in Crohn1s patients with fistulizing disease. American Journal of Gastroenterology (No. 5), 98, 1101.
13. Guimbaud, R., Bertrand, V., Chauvelot-Moachon, L., Quartier, G., Vidon, N., Giroud, J., Couturier, D. & Chaussade, S. (1998) Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. The American Journal of Gastroenterology(No. 12), 93, 2397.
14. Hajeer, A.H. & Hutchinson, I.V. (2001) Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Human Immunology, 62, 1191.
15. van Heel, D.A., Fisher, S.A., Kirby, A., Daly, M.J., Rioux, J.D. & Lewis, C.M. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Human Molecular Genetics, 13, 763.
16. Kamali-Sarvestani, E., Gharesi-Fard, B., Sarvari, J. & Talei, A.A. (2005) Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients. Pathology and Oncology Research, 11, 99Epub 2005 Jul 1.
17. Kim, T.H., Kim, B.G., Shin, H.D., Kim, J.W., Kim, C.G., Kim, J.S. et al. (2003) Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease. The Korean Journal of Gastroenterology, 42, 377.
18. Klein, W., Tromm, A., Griga, T., Fricke, H., Folwaczny, C., Hocke, M. et al. (2000) The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis, 2, 3578.
19. Koss, K., Satsangi, J., Fanning, G.C., Welsh, K.I. & Jewell, D.P. (2000) Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel disease and normal controls: differential effects on production and allele frequencies. Genes and Immunity, 1, 185.
20. Lech-Maranda, E., Baseggio, L., Bienvenu, J., Charlot, C., Berguer, F., Rigal, D. et al. (2004) Interleukin-10 gene promotor polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood, 13, 3529.
21. Lennard-Jones, J.E. (1989) Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology, Suppl 170, 2.
22. López-Hernández, R., Valdés, M., Lucas, D., Campillo, J.A., Martínez-Garcia, P., Salama, H. et al. (2010) Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Human Immunology, 71, 512.
23. López-Hernández, R., Valdés, M., Campillo, J.A., Martínez-García, P., Salama, H., Bolarin, J.M. et al. (2015) Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease. International Journal of Immunology, 42, 38.
24. Louis, E. & Belaiche, J. (2000) Genetics of Crohn's disease behavior. Acta Gastroenterologica Belgica, 63, 377.
25. Mendonza, J.L., Urcelay, E., Lana, R., Martínez, A., Taxonera, C., de la Concha, E.G. & Díaz-Rubio, M. (2006) Polymorphism in the interleukin-10 gene and relation to phenotype in patients with ulcerative colitis. Revista Española de Enfermedades Digestivas (Madrid), 98, 93.
26. Muro, M., López-Hernández, R. & Mrowiec, A. (2014) Immunogenetics biomarkers in inflammatory bowel disease: role of the IBD3 region. World Journal of Gastroenterology, 20, 15037.
27. Nosratollah, N., Alma, F., Tahereh, D., Manijeh, H., Hedie, B., Farzad, F., Aydin, M., Masoumeh, S. & Mohammadreza, Z. (2014) Association of tumor necrosis factor alpha gene polymorphisms with inflammatory bowel disease in Iran. Iranian Journal of Public Health, 43, 630.
28. Perrey, C., Turner, S.J., Pravica, V., Howell, W.M. & Hutchinson, I.V. (1999) ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transplant Immunology, 7, 127.
29. Richard Hansen, R., Cameron, F.L., Hold, G.L., El-Omar, E.M. & Russel, R.K. (2010) Inflammatory bowel disease. Paediatrics and Child Health, 20, 473.
30. Sanchez, R., Levy, E., Costea, F. & Sinnett, D. (2009) IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World Journal of Gastroenterology, 15, 3776.
31. Senhaji, N., Serrano, A., Badre, W., Serbati, N., Karkouri, M., Zaid, Y., Nadifi, S. & Martin, J. (2016) Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort. Genes and Immunity, 17, 60.
32. Shih, D.Q., Targan, S.R. & McGovern, D. (2008) Recent advances in IBD pathogenesis: genetics and immunobiology. Current Gastroenterology Reports, 10, 568.
33. Stewart, J.P., Behm, F.G., Arrand, J.R. & Rooney, C.M. (1994) Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology, 200, 724.
34. Szigethy, E., Laura McLafferty, L. & Goyal, A. (2010) Inflammatory bowel disease. Child and Adolescent Psychiatric Clinics of North America, 19, 301.
35. Tagore, A., Gonsalkorale, W.M., Pravica, V., Hajeer, A.H., McMahon, R., Whorwell, P.J. et al. (1999) Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens, 54, 386.
36. Vatay, A., Bene, L., Kovács, A., Prohászka, Z., Szalai, C., Romics, L. et al. (2003) Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics, 55, 247.
37. Wang, A.H., Lam, W.J., Han, D.Y., Ding, Y., Hu, R., Fraser, A.G. et al. (2011) The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Human Immunology, 72, 431.
38. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. & Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 3195.
39. Yamamoto-Furusho, J.K., Uscanga, L.F., Vargas-Alarcón, G., Rodríguez-Pérez, J.M., Zuñiga, J. & Granados, J. (2004) Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-α) and the HLA-DRB1 locus in Mexican Mestizo patients with ulcerative colitis. Immunology Letters, 95, 31.
40. Yang, S.K., Lee, S.G., Cho, Y.K., Lim, J., Lee, I. & Song, K. (2006) Association of TNF-α/LTA polymorphisms with Crohn's disease in Koreans. Cytokine, 35, 13.
41. Zipperlen, K., Peddle, L., Melay, B., Hefferton, D. & Rahman, P. (2005) Association of TNF-α Polymorphisms in Crohn Disease. Human Immunology, 66, 56.